Lupin Limited has informed the Exchange about press release dated 03-Mar-2022 titled Lupin Receives Approval from U.S. FDA for Efinaconazole Topical Solution.
Lupin Limited has informed the Exchange about press release dated 03-Mar-2022 titled Lupin Receives Approval from U.S. FDA for Efinaconazole Topical Solution.